These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 30802466)

  • 1. An expanding world of new psychoactive substances-designer benzodiazepines.
    Zawilska JB; Wojcieszak J
    Neurotoxicology; 2019 Jul; 73():8-16. PubMed ID: 30802466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'New/Designer Benzodiazepines': An Analysis of the Literature and Psychonauts' Trip Reports.
    Orsolini L; Corkery JM; Chiappini S; Guirguis A; Vento A; De Berardis D; Papanti D; Schifano F
    Curr Neuropharmacol; 2020; 18(9):809-837. PubMed ID: 31933443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of new psychoactive substances to mimic prescription drugs: The trend in France.
    Batisse A; Eiden C; Peyriere H; Djezzar S;
    Neurotoxicology; 2020 Jul; 79():20-24. PubMed ID: 32240674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emergence of new psychoactive substance (NPS) benzodiazepines: A review.
    Manchester KR; Lomas EC; Waters L; Dempsey FC; Maskell PD
    Drug Test Anal; 2018 Jan; 10(1):37-53. PubMed ID: 28471096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Synthetic Drugs - An Overview of Important and Newly Emerging Substances].
    Betzler F; Heinz A; Köhler S
    Fortschr Neurol Psychiatr; 2016 Nov; 84(11):690-698. PubMed ID: 27846654
    [No Abstract]   [Full Text] [Related]  

  • 6. An Expanding World of Novel Psychoactive Substances: Opioids.
    Zawilska JB
    Front Psychiatry; 2017; 8():110. PubMed ID: 28713291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designer Benzodiazepines: Another Class of New Psychoactive Substances.
    Moosmann B; Auwärter V
    Handb Exp Pharmacol; 2018; 252():383-410. PubMed ID: 30367253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Evolving Landscape of Designer Drugs.
    Kacinko SL; Papsun DM
    Methods Mol Biol; 2019; 1872():129-135. PubMed ID: 30350286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging Agents of Substance Use/Misuse.
    Michienzi AE; Borek HA
    Emerg Med Clin North Am; 2022 May; 40(2):265-281. PubMed ID: 35461623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Psychoactive Substances (NPS) - the Hydra monster of recreational drugs.
    Helander A; Bäckberg M
    Clin Toxicol (Phila); 2017 Jan; 55(1):1-3. PubMed ID: 27549399
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood concentrations of new designer benzodiazepines in forensic cases.
    Høiseth G; Tuv SS; Karinen R
    Forensic Sci Int; 2016 Nov; 268():35-38. PubMed ID: 27685473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New and Emerging Illicit Psychoactive Substances.
    Graddy R; Buresh ME; Rastegar DA
    Med Clin North Am; 2018 Jul; 102(4):697-714. PubMed ID: 29933824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic drugs of abuse.
    Tamama K
    Adv Clin Chem; 2021; 103():191-214. PubMed ID: 34229850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and identification of eight designer benzodiazepine metabolites by incubation with human liver microsomes and analysis by a triple quadrupole mass spectrometer.
    El Balkhi S; Chaslot M; Picard N; Dulaurent S; Delage M; Mathieu O; Saint-Marcoux F
    Int J Legal Med; 2017 Jul; 131(4):979-988. PubMed ID: 28160051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designer drugs – still a threat?
    Rozenek EB; Wilczyńska K; Górska M; Waszkiewicz N
    Przegl Epidemiol; 2019; 73(3):337-347. PubMed ID: 31766831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New psychoactive substances: An actual problem or an overestimated phenomenon?
    Vaiano F; Pascali JP; Bertol E
    Forensic Sci Int; 2019 Nov; 304():109941. PubMed ID: 31574421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deconstructing Designer Drugs.
    Sellers EM
    Clin Pharmacol Ther; 2017 Feb; 101(2):167-169. PubMed ID: 27564430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrotoxic effects of designer drugs: synthetic is not better!
    Luciano RL; Perazella MA
    Nat Rev Nephrol; 2014 Jun; 10(6):314-24. PubMed ID: 24662435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of new psychoactive substances in Northeast Asia from 2007 to 2015.
    Lee J; Yang S; Kang Y; Han E; Feng LY; Li JH; Chung H
    Forensic Sci Int; 2017 Mar; 272():1-9. PubMed ID: 28088088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicology in international drug control-Prioritizing the most harmful, persistent and prevalent substances.
    Ifeagwu SC; Raithelhuber M; Crean C; Gerostamoulos D; Chung H; Tettey JN
    Forensic Sci Int; 2017 May; 274():2-6. PubMed ID: 27899215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.